K
Kyu-Yup Lee
Researcher at Kyungpook National University
Publications - 121
Citations - 1775
Kyu-Yup Lee is an academic researcher from Kyungpook National University. The author has contributed to research in topics: Hearing loss & Ototoxicity. The author has an hindex of 21, co-authored 110 publications receiving 1448 citations. Previous affiliations of Kyu-Yup Lee include Kyungpook National University Hospital.
Papers
More filters
Journal ArticleDOI
Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation.
TL;DR: The role of quantitative measurement of peripheral lymphocyte subsets, especially CD4+ helper T-cell recovery, in predicting transplant outcomes including overall survival (OS) and non-relapse mortality (NRM) after allogeneic stem cell transplantation is evaluated.
Journal ArticleDOI
Pathophysiology of Age-Related Hearing Loss (Peripheral and Central)
TL;DR: This study reviews the literature on the age-related hearing loss and finds that metabolic presbycusis is the mainstay of pres bycusis types, and functional decline of the central auditory system, caused by aging, reduces speech-understanding in noisy background and increase temporal processing deficits in gap-detection measures.
Journal ArticleDOI
Targeted massive parallel sequencing: the effective detection of novel causative mutations associated with hearing loss in small families
Jeong-In Baek,Se-Kyung Oh,Dong-Bin Kim,Soo Young Choi,Un-Kyung Kim,Kyu-Yup Lee,Sang-Heun Lee +6 more
TL;DR: This report is the first documenting the effective use of an NGS technique to detect pathogenic mutations that underlie hearing loss in an East Asian population.
Journal ArticleDOI
Effective PEI-mediated delivery of CRISPR-Cas9 complex for targeted gene therapy.
Nari Ryu,Min-A Kim,Dongsik Park,Byeonghyeon Lee,Ye-Ri Kim,Kyung-Hee Kim,Jeong-In Baek,Won Jong Kim,Kyu-Yup Lee,Un-Kyung Kim,Un-Kyung Kim +10 more
TL;DR: It is demonstrated that BPEI-25K is a promising non-viral vector to deliver the CRISPR/Cas9 system in vitro to mediate targeted gene therapy, and these findings contribute to an understanding of CRISpr/ Cas9 delivery that may enable development of successful in vivo techniques.
Journal ArticleDOI
Methionine Sulfoxide Reductase B3-Targeted In Utero Gene Therapy Rescues Hearing Function in a Mouse Model of Congenital Sensorineural Hearing Loss.
Min-A Kim,Hyun-Ju Cho,Seung-Hyun Bae,Byeonghyeon Lee,Se-Kyung Oh,Tae-Jun Kwon,Zae Young Ryoo,Hwa-Young Kim,Jin-Ho Cho,Un-Kyung Kim,Kyu-Yup Lee +10 more
TL;DR: This is the first study to demonstrate functional and morphological rescue of the hair cells of the inner ear in the MsrB3 deficiency mouse model of congenital genetic sensorineural hearing loss using an in utero, virus-mediated gene therapy approach.